NCT00205816View on ClinicalTrials.gov

Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.

PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Bacterial Infections
Interventions
DRUG

Tigecycline

Trial Locations (3)

D-69120

Heidelberg

80-952

Gdansk

60-355

Poznan

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00205816 - Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens. | Biotech Hunter | Biotech Hunter